| Affiliation: | 1. Division of Endocrinology and Metabolism, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada;2. Division of Prevention and Rehabilitation, University of Ottawa, Heart Institute, Ottawa, Ontario, Canada;3. Clinical Services, University of Ottawa Heart Institute, Ottawa, Ontario, Canada;4. Ottawa Hospital Research Institute, Ottawa, Ontario, Canada;5. Division of Orthopedic Surgery, University of Ottawa, Ottawa, Ontario, Canada;1. Department of Dermatology, Hôtel-Dieu University Hospital, Nantes, France;2. Inserm U 892, CIC, Hôtel-Dieu, Nantes, France;3. Department of Pathology, University Hospital of Nantes, Nantes, France;1. Tor Vergata University Hospital, Rome, Italy;2. Department of Neurology, Cincinnati Children''s Hospital Medical Center, Cincinnati, OH, USA;3. Tuberous Sclerosis Multidisciplinary Management Clinic, Sydney Children''s Hospital, Sydney, NSW, Australia;4. Division of Child Neurology, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey;5. National Hospital Organization Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan;6. Paediatric Epileptology, Mara Hospital, Bethel Epilepsy Center, Bielefeld, Germany;7. Hospital Necker-Enfants Malades, Paris Descartes University, Paris, France;8. Division of Child and Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa;9. Departments of Neurology and Pediatrics, The Children''s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;10. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;11. Novartis Pharmaceuticals SAS, Paris, France;12. New York University Comprehensive Epilepsy Center, New York, NY, USA;1. Department of Medical Oncology, Clinical Trial Unit, Institut Curie, Paris, France;2. Department of Ophthalmology, Institut Curie, Paris, France;3. Institut Curie/INSERM U900, Paris, France |
